SCHEDULE: Sirenia Capital Management Reports 6.1% Stake in InflaRx

Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 6.1% of InflaRx N.V.'s ordinary shares.

Summary

• Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, indicating their beneficial ownership of 8,911,348 ordinary shares of InflaRx N.V.
• This ownership stake represents 6.1% of the total outstanding ordinary shares.
• The filing is made under Rule 13d-1(b) and indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of influencing control of the issuer.
• The reporting persons are Sirenia Capital Management LP (a Delaware limited partnership) and Alex Silverstein (a U.S. citizen), who is the managing member of Sirenia's general partner.
• The address for both reporting persons is 1674 Meridian Avenue, Suite 320, Miami Beach, FL 33139.
• The total number of outstanding ordinary shares used for the percentage calculation is 147,292,859.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without new financial or strategic information.

Positives

• Reporting persons are acting in the ordinary course of business and not seeking to influence control, suggesting a passive investment approach.
• The filing clearly states the beneficial ownership percentage (6.1%) and the number of shares held (8,911,348).

Negatives

• No new financial performance data or strategic updates are provided in this filing.

Risks

• The filing does not contain specific risk factors beyond the general risks associated with stock ownership and market fluctuations.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Management Comments

• "The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934 (the "Act"), the beneficial owner of the securities reported herein."
• "Sirenia and Mr. Silverstein have entered into a Joint Filing Agreement... pursuant to which they have agreed to file this Schedule 13G jointly..."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities..."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment managers accumulating significant stakes in public companies. This filing indicates a notable investment by Sirenia Capital Management LP in InflaRx N.V., a biotechnology company.

Comparison to Industry Standards

• This filing is a standard Schedule 13G, which is the prescribed form for reporting beneficial ownership of more than 5% of a class of securities by passive investors.
• The 6.1% ownership stake is a common threshold for institutional investors to report under SEC regulations.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding a significant institutional investor's stake, which may influence market perception.
• Management of InflaRx N.V.: The company is now aware of Sirenia Capital Management LP's 6.1% beneficial ownership.

Next Steps

• The reporting persons will continue to hold their shares in InflaRx N.V.
• Any future changes in beneficial ownership exceeding reporting thresholds will require subsequent filings.

Key Dates

Keywords

InflaRx N.V., Schedule 13G, Beneficial Ownership, Sirenia Capital Management LP, Alex Silverstein, Ordinary Shares, Investment Management, SEC Filing